Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients

Bordils, 2005, Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients, Transplant Proc, 37, 3756, 10.1016/j.transproceed.2005.10.074 Caliendo, 2000, Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients, J Clin Microbiol, 38, 2122, 10.1128/JCM.38.6.2122-2127.2000 Gallina, 1996, Human cytomegalovirus pp65 lower matrix phosphoprotein harbours two transplantable nuclear localization signals, J Gen Virol, 77, 1151, 10.1099/0022-1317-77-6-1151 Gerna, 2007, Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study, Antivir Ther, 12, 63, 10.1177/135965350701200108 Gerna, 2000, Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events, J Virol, 74, 5629, 10.1128/JVI.74.12.5629-5638.2000 Grundy, 1998, Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration, J Infect Dis, 177, 1465, 10.1086/515300 Hernando, 2005, Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients, Transplant Proc, 37, 4094, 10.1016/j.transproceed.2005.10.087 Huggett, 2005, Real-time RT-PCR normalisation; strategies and considerations, Genes Immun, 6, 279, 10.1038/sj.gene.6364190 Ikewaki, 2005, Real-time PCR assays based on distinct genomic regions for cytomegalovirus reactivation following hematopoietic stem cell transplantation, Bone Marrow Transplant, 35, 403, 10.1038/sj.bmt.1704791 Kas-Deelen, 2001, Uptake of pp65 in in vitro generated pp65-positive polymorphonuclear cells mediated by phagocytosis and cell fusion?, Intervirology, 44, 8, 10.1159/000050024 Kalpoe, 2004, Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection, J Clin Microbiol, 42, 1498, 10.1128/JCM.42.4.1498-1504.2004 Kim, 2007, Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients, Transplant Proc, 39, 1458, 10.1016/j.transproceed.2007.01.088 Kusne, 1999, Prevention and treatment of cytomegalovirus infection in organ transplant recipients, Transplant Infect Dis, 1, 187, 10.1034/j.1399-3062.1999.010307.x Kusne, 1999, Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients, Transplantation, 68, 1125, 10.1097/00007890-199910270-00011 Li, 2003, Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients, J Clin Microbiol, 41, 187, 10.1128/JCM.41.1.187-191.2003 Lilleri, 2007, Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia, Blood, 110, 2757, 10.1182/blood-2007-03-080820 Lilleri, 2004, Clinically based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients, J Med Virol, 73, 412, 10.1002/jmv.20107 Ljungman, 2002, Definitions of cytomegalovirus infection and disease in transplant recipients, Clin Infect Dis, 34, 1094, 10.1086/339329 Razonable, 2002, The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease, Transplantation, 73, 968, 10.1097/00007890-200203270-00025 Razonable, 2004, Management of CMV infection and disease in transplant patients, Herpes, 11, 77 Rinaldo, 1977, Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus, J Infect Dis, 136, 667, 10.1093/infdis/136.5.667 Roback, 2001, Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors, Transfusion, 41, 1249, 10.1046/j.1537-2995.2001.41101249.x Ruell, 2007, Active CMV disease does not always correlate with viral load detection, Bone Marrow Transplant, 40, 55, 10.1038/sj.bmt.1705671 Schmolke, 1995, Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport, J Virol, 69, 1071, 10.1128/JVI.69.2.1071-1078.1995 Slifkin, 2001, Late and atypical cytomegalovirus disease in solid-organ transplant recipients, Clin Infect Dis, 33, E62, 10.1086/322663 St. George, 1997, Comparison of commercially available antibody reagents for the cytomegalovirus pp65 antigenemia assay, Clin Diagn Virol, 7, 147, 10.1016/S0928-0197(96)00264-4 Stocher, 2002, Normalized quantification of human cytomegalovirus DNA by competitive real-time PCR on the LightCycler instrument, J Clin Microbiol, 40, 4547, 10.1128/JCM.40.12.4547-4553.2002 van Doornum, 2003, Diagnosing herpesvirus infections by real-time amplification and rapid culture, J Clin Microbiol, 41, 576, 10.1128/JCM.41.2.576-580.2003 Zanghellini, 1999, Asymptomatic primary cytomegalovirus infection: virologic and immunologic features, J Infect Dis, 180, 702, 10.1086/314939 Zhang, 1995, Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood, J Infect Dis, 171, 1002, 10.1093/infdis/171.4.1002